<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Parkinsons Dis</journal-id><journal-id journal-id-type="iso-abbrev">Parkinsons Dis</journal-id><journal-id journal-id-type="publisher-id">PD</journal-id><journal-title-group><journal-title>Parkinson's Disease</journal-title></journal-title-group><issn pub-type="ppub">2090-8083</issn><issn pub-type="epub">2042-0080</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5030423</article-id><article-id pub-id-type="doi">10.1155/2016/3474751</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Analysis of<italic> LRRK2</italic>,<italic> SNCA,</italic> and<italic> ITGA8</italic> Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0030-8393</contrib-id><name><surname>Yi</surname><given-names>Kehui</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5480-8596</contrib-id><name><surname>Guo</surname><given-names>Mingwei</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1842-6387</contrib-id><name><surname>An</surname><given-names>Xingkai</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0201-4310</contrib-id><name><surname>Qu</surname><given-names>Hongli</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9726-8913</contrib-id><name><surname>Lin</surname><given-names>Qing</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8768-6137</contrib-id><name><surname>Bi</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1387-2647</contrib-id><name><surname>Ma</surname><given-names>Qilin</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Neurology, The First Affiliated Hospital of Xiamen University, Xiamen, China</aff><aff id="I2"><sup>2</sup>The First Clinical Medical College of Fujian Medical University, Fuzhou, China</aff><aff id="I3"><sup>3</sup>Department of Neurology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China</aff><author-notes><corresp id="cor1">*Qilin Ma: <email>qilinma@yeah.net</email></corresp><fn fn-type="other"><p>Academic Editor: Eng King Tan</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>7</day><month>9</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>3474751</elocation-id><history><date date-type="received"><day>21</day><month>5</month><year>2016</year></date><date date-type="rev-recd"><day>1</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>8</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Jie Fang et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background</italic>. Parkinson's disease (PD) is an age-related neurodegenerative disease affected by multiple genetic and environmental factors. We performed a case-control study on candidate gene to scrutinize whether genetic variants in<italic> LRRK2</italic>,<italic> SNCA</italic>, and<italic> ITGA8</italic> genes could be associated with sporadic PD in Chinese Han population.<italic> Methods</italic>. Five single-nucleotide polymorphisms (SNPs) of<italic> LRRK2</italic> (rs1491942),<italic> SNCA</italic> (rs2301134, rs2301135, and rs356221), and<italic> ITGA8</italic> (rs7077361) were selected and genotyped among 583 unrelated PD patients and 558 healthy controls.<italic> Results</italic>. Rs1491942 of<italic> LRRK2</italic> gene had a significantly higher genotype frequency (<italic>P</italic> = 3.543E &#x02212; 09) and allelic G/C frequencies (<italic>P</italic> = 2.601E &#x02212; 10) in PD patients than controls. Rs2301135 of<italic> SNCA</italic> gene also showed an obvious difference in genotype frequency (<italic>P</italic> = 4.394E &#x02212; 07) and allelic G/C frequencies (<italic>P</italic> = 9.116E &#x02212; 13) between PD patients and controls. SNPs rs2301134 and rs356221 of<italic> SNCA</italic> gene and rs7077361 of<italic> ITGA8</italic> gene lacked the significant association with the susceptibility of PD in Chinese Han population.<italic> Conclusions</italic>. Our study firstly expresses that rs1491942 of<italic> LRRK2</italic> and rs2301135 of<italic> SNCA</italic> gene are substantially associated with sporadic Parkinson's disease in Chinese Han population.</p></abstract><funding-group><award-group><funding-source>Fujian Medical Technology Innovation Programs</funding-source><award-id>2014-CXB-33</award-id></award-group><award-group><funding-source>Xiamen Important Joint Research Project of Major Diseases</funding-source><award-id>3502Z20149028</award-id></award-group><award-group><funding-source>Science and Technology Program of Xiamen</funding-source><award-id>3502Z20154014</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>81400912</award-id></award-group><award-group><funding-source>Natural Science Foundation of Fujian Province</funding-source><award-id>2015J01544</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Parkinson's disease (PD), the second most common neurodegenerative disease after Alzheimer's disease, consists of two major pathological hallmarks: loss of dopaminergic neurons and the presence of Lewy bodies (LB). The classic manifestations of PD are characterized by resting tremor, rigidity, bradykinesia, and impairment of postural reflexes. In addition, some untypical nonmotor features, such as sleep disturbances, mood disorders, autonomic dysfunction, sensory problems, and cognitive impairment, are highly concerned recently. Even when treated with effective therapies, PD is progressive and somehow leads to disability or even mortality.</p><p>Increasing evidence supports that complex factors contribute a lot to the susceptibility of PD, which includes genetic and environmental factors [<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>]. In the past decades, a large number of Genome-Wide Association Studies (GWAS), Candidate Gene Replication Study (CGRS), and subsequent meta-analysis studies have found that a number of potential genes and single-nucleotide polymorphisms (SNPs) associated with PD, including both risk variants and protective variants [<xref rid="B4" ref-type="bibr">4</xref>]. In addition, the previous candidate genetic studies provided conclusive evidence showing SNPs in<italic> LRRK2</italic>,<italic> SNCA</italic>, and<italic> ITGA8</italic> genes significantly impact PD susceptibility and disease characteristics.</p><p>Several variations of<italic> LRRK2</italic> gene were identified as risk factors for PD. For example, rs34778348 (G2385R, c.7153G&#x0003e;A) and rs33949390 (R1628P, c.4883G&#x0003e;C) were seen to associate with PD in Asian population [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. Another novel SNP within<italic> LRRK2</italic>, rs1491942, was found to be responsible for PD in Caucasian populations [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. However, it was never reported in Chinese Han population before.</p><p>
<italic>SNCA</italic>, as the first pathogenic gene identified in PD, encodes <italic>&#x003b1;</italic>-synuclein, the primary component of LB, the pathological hallmark of PD. From then on, several SNPs of<italic> SNCA</italic> were highly considered as the genetic risk factors for sporadic PD. Located in the promoter region of<italic> SNCA</italic>, two SNPs (rs2301134 and rs2301135) with high allele frequency were reported in some studies as PD-related SNPs in European and Taiwanese cohorts [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>]. One SNP (rs356221) in the 3&#x02032;UTR region of<italic> SNCA</italic> gene showed association with susceptibility to sporadic PD in Japanese and Taiwanese cohorts [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. All these three SNPs of<italic> SNCA</italic> (rs2301134, rs2301135, and rs356221) have not been investigated in Han population on the Mainland of China.</p><p>While<italic> ITGA8</italic> (encoding integrin alpha 8, a type-I transmembrane protein) gene was firstly proved to connect with idiopathic PD in Caucasian population in Sim&#x000f3;n-S&#x000e1;nchez's study [<xref rid="B4" ref-type="bibr">4</xref>], it was not featured as a PD relevant gene until Lill's study revealed its potential association with PD [<xref rid="B8" ref-type="bibr">8</xref>]. Additional studies are needed to screen the potential pathogenic variants within this gene and assess the potential role of these variants in PD pathogenesis.</p><p>There are no study that explores the association of the three genes and their SNPs with Parkinson's disease in Chinese Han population. Here, we perform the first SNP replication study on previously published SNPs within<italic> SNCA</italic> (rs356221, rs2301134, and rs2301135),<italic> LRRK2</italic> (rs1491942), and<italic> ITGA8</italic> (rs7077361) gene in Chinese Han population to explore the ethnic differences and recognize predictive factors for the diagnosis of PD.</p></sec><sec id="sec2"><title>2. Methods</title><sec id="sec2.1"><title>2.1. Subjects</title><p>This study recruits 1136 cases in the Neurology Department of the First Affiliated Hospital of Xiamen University, which includes 583 Chinese Han sporadic PD patients and 553 matched healthy controls. PD diagnosis coincided well with the diagnostic criteria of UK Parkinson's Disease Society Brain Bank [<xref rid="B12" ref-type="bibr">12</xref>]. Among all the PD patients, the mean age is 65.10 &#x000b1; 8.90 and the ratio of male to female patients is 320&#x02009;:&#x02009;263. The group of controls consists of healthy volunteers from the Medical Center of the First Affiliated Hospital of Xiamen University, the mean age of which is 65.37 &#x000b1; 9.03, and the ratio of male to female patients is 286&#x02009;:&#x02009;267 (<xref ref-type="table" rid="tab1">Table 1</xref>). All subjects are Han population, and the two groups are matched for age, gender, ethnicity, and area of residence. Moreover, this study has gained approval of the local ethics committees, and all patients and controls signed informed consents.</p></sec><sec id="sec2.2"><title>2.2. Genetic Analysis</title><p>Venous blood specimens are collected directly from all PD patients and the healthy controls with ethylene diamine tetraacetic acid (EDTA) anticoagulant. Genomic DNA is extracted from the blood samples with the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) under the manufacturer's instructions and stored at &#x02212;20&#x000b0;C. The five SNPs are genotyped by Multiplex Snapshot technique (Applied Biosystems by Life Technologies, Foster City, CA, USA). The primers are designed for each SNP locus using Primer 5 and listed in <xref ref-type="table" rid="tab2">Table 2</xref>. Multiplex PCR reactions are performed to amplify target regions containing the selected SNPs. All products are analyzed by the ABI PRISM 3730 DNA Sequence, of which the sequence analyses are conducted by DNA Sequencing Analysis software, GeneMapper4.0. To confirm the results, 10% patients and 10% controls are randomly selected for Sanger sequencing approaches. The concordance rate for replicate approaches was 100%.</p></sec><sec id="sec2.3"><title>2.3. Statistical Analysis</title><p>The statistical analyses are processed with SPSS, version 20.0 (IBM, Armonk, NY, USA). The clinical data are expressed as the means &#x000b1; standard deviation (SD) for the continuous variables and as numbers (percentage) for the quantitative variables. Student's<italic> t</italic>-test is used to compare the age variables between the patients and controls. The gender variables are assessed by the chi-square test. Differences in frequencies of the alleles and genotypes between cases and controls are tested for each SNP through Pearson's chi-square test and Fisher's exact test. The criterion for significance is set at <italic>P</italic> &#x0003c; 0.05 based on two sides for all of the tests. The statistical power is calculated by Power and Sample Size Calculations version 3.1.2. The Hardy-Weinberg equilibrium (HWE) is tested by adopting the public statistics web tool (<ext-link ext-link-type="uri" xlink:href="http://ihg.gsf.de/cgi-bin/hw/hwa1.pl">http://ihg.gsf.de/cgi-bin/hw/hwa1.pl</ext-link>). The Haploview program [<xref rid="B13" ref-type="bibr">13</xref>] is used for the calculation of linkage disequilibrium (LD) among the three SNPs in<italic> SNCA.</italic>
</p></sec></sec><sec id="sec3"><title>3. Results </title><p>Genotype and allele frequencies of each SNP of all 1136 subjects (583 patients and 553 healthy controls) are shown in <xref ref-type="table" rid="tab3">Table 3</xref>. Among PD patients, 131 (22%) had an early age of onset (&#x0003c;50 years) and around 77% of the patients were LOPD (&#x02267;50 years). The age (<italic>P</italic> = 0.860) and gender (<italic>P</italic> = 0.284) show no statistical difference between the PD patients and the controls in our study. All the subjects were ethnic Hans.</p><p>Linkage disequilibrium between the<italic> SNCA</italic> SNPs rs2301134 and rs356221 is <italic>r</italic>
<sup>2</sup> = 0.235, while for rs356221 and rs2301135 it is <italic>r</italic>
<sup>2</sup> = 0.066 and for rs2301134 and rs2301135 it is <italic>r</italic>
<sup>2</sup> = 0.127. This shows weakly correlation with in rs2301134, rs2301135, and rs356221.</p><p>Single marker analysis showed a number of significantly statistical associations in our study. Two SNPs from<italic> SNCA</italic> and<italic> LRRK2</italic> genes displayed <italic>P</italic> values &#x0003c; 0.05 prior to correction, both of which were estimated ORs &#x0003e; 1.4. The best <italic>P</italic> value SNPs from both<italic> LRRK2</italic> and<italic> SNCA</italic> genes were further analyzed for age stratification.</p><p>Between all PD patients and controls,<italic> LRRK2</italic> gene showed a significant difference in the genotype frequency of variant rs1491942 (<italic>P</italic> = 3.543E &#x02212; 09) and allelic G/C frequencies (<italic>P</italic> = 2.601E &#x02212; 10, OR = 1.884, and 95% CI: 1.55&#x02013;2.30). In the three SNPs of<italic> SNCA</italic> gene, only variant rs2301135 met the statistics standard in genotype frequencies (<italic>P</italic> = 4.39E &#x02212; 07) and the allelic G/C frequencies (<italic>P</italic> = 9.116E &#x02212; 13, OR = 7.857, and 95% CI: 4.05&#x02013;15.26). The<italic> ITGA8</italic> variant rs7077361 failed to show significant difference in this group (<italic>P</italic> &#x0003e; 0.05).</p><p>In the subgroup of EOPD patients and the controls (age &#x0003c; 50 years), the differences were still obvious in the genotype frequencies of variant rs1491942 of<italic> LRRK2</italic> gene (<italic>P</italic> = 1.200E &#x02212; 02) and allelic G/C frequencies (<italic>P</italic> = 3.028E &#x02212; 03, OR = 1.924, and 95% CI: 1.24&#x02013;2.98). Three SNPs of<italic> SNCA</italic> gene (<italic>P</italic> &#x0003e; 0.05) and one SNP of<italic> ITGA8</italic> gene (<italic>P</italic> &#x0003e; 0.05) failed to show significant difference in this group. Our statistic data of the LOPD patients and controls aged &#x02267; 50 years also surpassed the significance thresholds. The variant rs1491942 of<italic> LRRK2</italic> gene showed a <italic>P</italic> value of 2.538E-07 in genotype frequencies. And the allelic G/C frequencies have a <italic>P</italic> value of 2.459E-08 while the OR is 1.874, and the 95% CI ranged from 1.50 to 2.34. The difference is obvious in the variant rs2301135 of<italic> SNCA</italic> gene in the genotype frequencies (<italic>P</italic> = 5.561E &#x02212; 07) and allelic G/C frequencies (<italic>P</italic> = 1.45E &#x02212; 12, OR = 7.846, and 95% CI: 4.03&#x02013;15.29) in the subgroup. All SNPs in our study met Hardy-Weinberg equilibrium except for the rs2301135 of<italic> SNCA</italic> gene, shown in <xref ref-type="table" rid="tab3">Table 3</xref>.</p></sec><sec id="sec4"><title>4. Discussion </title><p>Since the first Genome-Wide Association Study on sporadic Parkinson's disease was performed in 2005, a new era starts to gain attention in the genetic basis of Parkinson's disease [<xref rid="B14" ref-type="bibr">14</xref>]. Advances in genotyping technology and meta-analysis have allowed researchers to rapidly identify common variants related to PD in different populations [<xref rid="B4" ref-type="bibr">4</xref>]. Though some of the previously nominated PD risk genes were firstly reported in familiar Parkinson's disease (such as<italic> SNCA</italic> and<italic> LRRK2</italic>), both of them were successfully replicated in unrelated sporadic PD patients [<xref rid="B15" ref-type="bibr">15</xref>]. Additional associated studies and subsequent meta-analysis contributed a lot to identifying the unnoticed variants that can also drive PD risk,<italic> ITGA8</italic> as an example [<xref rid="B8" ref-type="bibr">8</xref>].</p><p>
<italic>LRRK2</italic> gene was firstly featured as a PD-related gene in Zimprich's study of families with autosomal-dominant, late-onset Parkinsonism in 2004 [<xref rid="B16" ref-type="bibr">16</xref>]. Variants in different domains of<italic> LRRK2</italic> have been identified in both familial and sporadic PD in different populations [<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B19" ref-type="bibr">19</xref>]. Rs1494942 in<italic> LRRK2</italic> was previously found associated with PD in US and European series [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B20" ref-type="bibr">20</xref>]. Our result, being consistent with previous studies, suggests that polymorphism rs1491942 of<italic> LRRK2</italic> is a risk loci of sporadic PD, and the variant carriers may share a similar pathomechanism in different populations. As it is reported,<italic> LRRK2</italic> variant carriers share similar clinical and pathological features, including a wild range of onset ages, typical Parkinsonism presentation, and sensitivity to L-dopa therapy [<xref rid="B21" ref-type="bibr">21</xref>]. In our PD patients, the rs1491942 shows significantly higher frequencies in both EOPD and LOPD subgroups compared with matched controls. These suggest that rs1491942 does not influence the onset age but contributes to the pathogenesis of EOPD and LOPD in a similar way.</p><p>
<italic>SNCA</italic> is the first identified causal gene in familial PD [<xref rid="B22" ref-type="bibr">22</xref>]. Our findings are partly consistent with previous reports of the association of polymorphisms in<italic> SNCA</italic> with the susceptibility of PD in US, Norway, and Italian studies [<xref rid="B23" ref-type="bibr">23</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>]. The linkage disequilibrium of three SNPs of<italic> SNCA</italic> gene showed that those SNPs are independent. Only one SNP near the promoter region (rs2301135) shows significant differences between PD patients and the controls in Chinese Han population. Concerning the age of onset, rs2301135 is more likely to associate with late-onset PD in our study, while another study in UK suggested that<italic> SNCA</italic> risk alleles for PD may associate with earlier onset of PD [<xref rid="B26" ref-type="bibr">26</xref>]. Given that genotype frequencies and allelic frequencies of rs2301135 of<italic> SNCA</italic> gene do not follow the Hardy-Weinberg equilibrium in our study, this suggests the possibility of inappropriate population stratification and selection or other confounding factors in our study. Therefore, these results should be interpreted carefully.</p><p>
<italic>ITGA8</italic> expressing in brain mediates cell-cell interactions and regulates neurite outgrowth of sensory and motor neurons [<xref rid="B8" ref-type="bibr">8</xref>].<italic> ITGA8</italic> gene was firstly shown associated with PD in Caucasian population in Sim&#x000f3;n-S&#x000e1;nchez's study but failed to replicate in other studies of Greece, Irish, and Polish series [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].<italic> ITGA8</italic> variant rs7077361 showed no evidence of relation to PD in our population. In patients and controls, the observed MAFs of the SNP rs7077361 were similar to those reported in the 1000 genomes Southern Han Chinese (CHS) population. However, there is insufficient power to detect the association of rs7077361 with PD in the current sample size. The lack of association of the rs7077361 in Chinese Han population could be ascribed to the limited sample size and the rare existence of this SNP in Chinese population. Large-sample trials from multicenter are required to better understand the contribution of rs7077361 in<italic> ITGA8</italic> to PD susceptibility.</p><p>In conclusion, the present study provides considerable evidence to support the significant influence of genetic variants on PD risk. It does not replicate the susceptibility of rs2301134 and rs356221 in<italic> SNCA</italic> and rs7077361 in<italic> ITGA8</italic> for PD but confirms that single-nucleotide polymorphisms rs1491942 of<italic> LRRK2</italic> and rs2301135 of S<italic>NCA</italic> gene are susceptible to sporadic PD in Chinese Han population. Certain variants are responsible for the incidence of this disease, while other variants may modify the onset age, which suggests that distinct aspects of PD have a specific genetic architecture. Further studies are required to enrich genetic architecture of PD.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank all the patients and control subjects who participated in this study. The authors would like to show many thanks to Jingjing Yin, a teacher from New Oriental English training school (E-mail: <ext-link ext-link-type="uri" xlink:href="mailto:yinjingjing@xdf.cn">yinjingjing@xdf.cn</ext-link>), for the substantial English editing. This work was supported by the Fujian Medical Technology Innovation Programs (no. 2014-CXB-33), Xiamen Important Joint Research Project of Major Diseases (no. 3502Z20149028), Science and Technology Program of Xiamen (no. 3502Z20154014), National Natural Science Foundation of China (no. 81400912), and Natural Science Foundation of Fujian Province (no. 2015J01544).</p></ack><sec><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' Contributions</title><p>Jie Fang and Kehui Yi contributed equally to this work as first authors.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalls</surname><given-names>M. A.</given-names></name><name><surname>Pankratz</surname><given-names>N.</given-names></name><name><surname>Lill</surname><given-names>C. M.</given-names></name><etal/></person-group><article-title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease</article-title><source><italic>Nature Genetics</italic></source><year>2014</year><volume>46</volume><issue>9</issue><fpage>989</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1038/ng.3043</pub-id><pub-id pub-id-type="other">2-s2.0-84939599004</pub-id><pub-id pub-id-type="pmid">25064009</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormack</surname><given-names>A. L.</given-names></name><name><surname>Thiruchelvam</surname><given-names>M.</given-names></name><name><surname>Manning-Bog</surname><given-names>A. B.</given-names></name><etal/></person-group><article-title>Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat</article-title><source><italic>Neurobiology of Disease</italic></source><year>2002</year><volume>10</volume><issue>2</issue><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2002.0507</pub-id><pub-id pub-id-type="other">2-s2.0-0036075892</pub-id><pub-id pub-id-type="pmid">12127150</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalinderi</surname><given-names>K.</given-names></name><name><surname>Bostantjopoulou</surname><given-names>S.</given-names></name><name><surname>Fidani</surname><given-names>L.</given-names></name></person-group><article-title>The genetic background of Parkinson's disease: current progress and future prospects</article-title><source><italic>Acta Neurologica Scandinavica</italic></source><year>2016</year><pub-id pub-id-type="doi">10.1111/ane.12563</pub-id><pub-id pub-id-type="other">2-s2.0-84958665773</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f3;n-S&#x000e1;nchez</surname><given-names>J.</given-names></name><name><surname>Schulte</surname><given-names>C.</given-names></name><name><surname>Bras</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Genome-wide association study reveals genetic risk underlying Parkinson's disease</article-title><source><italic>Nature Genetics</italic></source><year>2009</year><volume>41</volume><fpage>1308</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/ng.487</pub-id><pub-id pub-id-type="pmid">19915575</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>M. J.</given-names></name><name><surname>Stone</surname><given-names>J. T.</given-names></name><name><surname>Lin</surname><given-names>C.-H.</given-names></name><etal/></person-group><article-title>Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia</article-title><source><italic>Parkinsonism &#x00026; Related Disorders</italic></source><year>2007</year><volume>13</volume><issue>2</issue><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2006.12.001</pub-id><pub-id pub-id-type="other">2-s2.0-33847267765</pub-id><pub-id pub-id-type="pmid">17222580</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>O. A.</given-names></name><name><surname>Wu</surname><given-names>Y.-R.</given-names></name><name><surname>Lee</surname><given-names>M.-C.</given-names></name><etal/></person-group><article-title>Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>2008</year><volume>64</volume><issue>1</issue><fpage>88</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/ana.21405</pub-id><pub-id pub-id-type="other">2-s2.0-48949092066</pub-id><pub-id pub-id-type="pmid">18412265</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalls</surname><given-names>M. A.</given-names></name><name><surname>Plagnol</surname><given-names>V.</given-names></name><name><surname>Hernandez</surname><given-names>D. G.</given-names></name><etal/></person-group><article-title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies</article-title><source><italic>The Lancet</italic></source><year>2011</year><volume>377</volume><issue>9766</issue><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)62345-8</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lill</surname><given-names>C. M.</given-names></name><name><surname>Roehr</surname><given-names>J. T.</given-names></name><name><surname>McQueen</surname><given-names>M. B.</given-names></name><etal/></person-group><article-title>Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDgene database</article-title><source><italic>PLoS Genetics</italic></source><year>2012</year><volume>8</volume><issue>3</issue><pub-id pub-id-type="publisher-id">e1002548</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002548</pub-id><pub-id pub-id-type="other">2-s2.0-84859339977</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>S.</given-names></name><name><surname>Hagenah</surname><given-names>J.</given-names></name><name><surname>Lincoln</surname><given-names>S.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein and Parkinson disease susceptibility</article-title><source><italic>Neurology</italic></source><year>2007</year><volume>69</volume><issue>18</issue><fpage>1745</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000275524.15125.f4</pub-id><pub-id pub-id-type="other">2-s2.0-35848966980</pub-id><pub-id pub-id-type="pmid">17872362</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu-Chou</surname><given-names>Y.-H.</given-names></name><name><surname>Chen</surname><given-names>Y.-T.</given-names></name><name><surname>Yeh</surname><given-names>T.-H.</given-names></name><etal/></person-group><article-title>Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2013</year><volume>19</volume><issue>2</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.10.019</pub-id><pub-id pub-id-type="other">2-s2.0-84873719976</pub-id><pub-id pub-id-type="pmid">23182315</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuta</surname><given-names>I.</given-names></name><name><surname>Satake</surname><given-names>W.</given-names></name><name><surname>Nakabayashi</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Multiple candidate gene analysis identifies <italic>&#x003b1;</italic>-<italic>synuclein</italic> as a susceptibility gene for sporadic Parkinson's disease</article-title><source><italic>Human Molecular Genetics</italic></source><year>2006</year><volume>15</volume><issue>7</issue><fpage>1151</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl030</pub-id><pub-id pub-id-type="other">2-s2.0-33645111633</pub-id><pub-id pub-id-type="pmid">16500997</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calne</surname><given-names>D. B.</given-names></name><name><surname>Snow</surname><given-names>B. J.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name></person-group><article-title>Criteria for diagnosing Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>1992</year><volume>32</volume><fpage>S125</fpage><lpage>S127</lpage><pub-id pub-id-type="doi">10.1002/ana.410320721</pub-id><pub-id pub-id-type="other">2-s2.0-0026695663</pub-id><pub-id pub-id-type="pmid">1510370</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>J. C.</given-names></name><name><surname>Fry</surname><given-names>B.</given-names></name><name><surname>Maller</surname><given-names>J.</given-names></name><name><surname>Daly</surname><given-names>M. J.</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title><source><italic>Bioinformatics</italic></source><year>2005</year><volume>21</volume><issue>2</issue><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id><pub-id pub-id-type="other">2-s2.0-13444269543</pub-id><pub-id pub-id-type="pmid">15297300</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>D. M.</given-names></name><name><surname>De Andrade</surname><given-names>M.</given-names></name><name><surname>Lesnick</surname><given-names>T. C.</given-names></name><etal/></person-group><article-title>High-resolution whole-genome association study of Parkinson disease</article-title><source><italic>The American Journal of Human Genetics</italic></source><year>2005</year><volume>77</volume><issue>5</issue><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1086/496902</pub-id><pub-id pub-id-type="other">2-s2.0-27244451809</pub-id><pub-id pub-id-type="pmid">16252231</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>O. A.</given-names></name><name><surname>Gosal</surname><given-names>D.</given-names></name><name><surname>Stone</surname><given-names>J. T.</given-names></name><etal/></person-group><article-title>Familial genes in sporadic disease: common variants of <italic>&#x003b1;</italic>-synuclein gene associate with Parkinson's disease</article-title><source><italic>Mechanisms of Ageing and Development</italic></source><year>2007</year><volume>128</volume><issue>5-6</issue><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2007.04.002</pub-id><pub-id pub-id-type="other">2-s2.0-34347383973</pub-id><pub-id pub-id-type="pmid">17531291</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimprich</surname><given-names>A.</given-names></name><name><surname>Biskup</surname><given-names>S.</given-names></name><name><surname>Leitner</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</article-title><source><italic>Neuron</italic></source><year>2004</year><volume>44</volume><issue>4</issue><fpage>601</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.11.005</pub-id><pub-id pub-id-type="other">2-s2.0-8844233579</pub-id><pub-id pub-id-type="pmid">15541309</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozelius</surname><given-names>L. J.</given-names></name><name><surname>Senthil</surname><given-names>G.</given-names></name><name><surname>Saunders-Pullman</surname><given-names>R.</given-names></name><etal/></person-group><article-title>LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2006</year><volume>354</volume><issue>4</issue><fpage>424</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1056/nejmc055509</pub-id><pub-id pub-id-type="other">2-s2.0-31344439221</pub-id><pub-id pub-id-type="pmid">16436782</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>S.</given-names></name><name><surname>D&#x000fc;rr</surname><given-names>A.</given-names></name><name><surname>Tazir</surname><given-names>M.</given-names></name><etal/></person-group><article-title>LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2006</year><volume>354</volume><issue>4</issue><fpage>422</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1056/nejmc055540</pub-id><pub-id pub-id-type="other">2-s2.0-31344432937</pub-id><pub-id pub-id-type="pmid">16436781</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>E.</given-names></name><name><surname>Xiromerisiou</surname><given-names>G.</given-names></name><name><surname>Spanaki</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Assessment of Parkinson's disease risk loci in Greece</article-title><source><italic>Neurobiology of Aging</italic></source><year>2014</year><volume>35</volume><issue>2</issue><fpage>442.e9</fpage><lpage>442.e16</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.07.011</pub-id><pub-id pub-id-type="other">2-s2.0-84887242321</pub-id><pub-id pub-id-type="pmid">24080174</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto-Ortolaza</surname><given-names>A. I.</given-names></name><name><surname>Heckman</surname><given-names>M. G.</given-names></name><name><surname>Labb&#x000e9;</surname><given-names>C.</given-names></name><etal/></person-group><article-title>GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16</article-title><source><italic>American Journal of Neurodegenerative Disease</italic></source><year>2013</year><volume>2</volume><fpage>287</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">24319646</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e4;chsel</surname><given-names>J. C.</given-names></name><name><surname>Farrer</surname><given-names>M. J.</given-names></name></person-group><article-title>LRRK2 and Parkinson disease</article-title><source><italic>Archives of Neurology</italic></source><year>2010</year><volume>67</volume><issue>5</issue><fpage>542</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2010.79</pub-id><pub-id pub-id-type="other">2-s2.0-77952122496</pub-id><pub-id pub-id-type="pmid">20457952</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>S.</given-names></name><name><surname>Brice</surname><given-names>A.</given-names></name></person-group><article-title>Parkinson's disease: from monogenic forms to genetic susceptibility factors</article-title><source><italic>Human Molecular Genetics</italic></source><year>2009</year><volume>18</volume><issue>1</issue><fpage>R48</fpage><lpage>R59</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp012</pub-id><pub-id pub-id-type="other">2-s2.0-63149090431</pub-id><pub-id pub-id-type="pmid">19297401</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>A. A.</given-names></name><name><surname>Andruska</surname><given-names>K. M.</given-names></name><name><surname>Benitez</surname><given-names>B. A.</given-names></name><name><surname>Racette</surname><given-names>B. A.</given-names></name><name><surname>Perlmutter</surname><given-names>J. S.</given-names></name><name><surname>Cruchaga</surname><given-names>C.</given-names></name></person-group><article-title>Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression</article-title><source><italic>Neurobiology of Aging</italic></source><year>2016</year><volume>37</volume><fpage>209.e1</fpage><lpage>209.e7</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.09.014</pub-id><pub-id pub-id-type="other">2-s2.0-84951075844</pub-id><pub-id pub-id-type="pmid">26601739</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myhre</surname><given-names>R.</given-names></name><name><surname>Toft</surname><given-names>M.</given-names></name><name><surname>Kachergus</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population</article-title><source><italic>Acta Neurologica Scandinavica</italic></source><year>2008</year><volume>118</volume><issue>5</issue><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0404.2008.01019.x</pub-id><pub-id pub-id-type="other">2-s2.0-46949094193</pub-id><pub-id pub-id-type="pmid">18485051</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotta</surname><given-names>L.</given-names></name><name><surname>Guella</surname><given-names>I.</given-names></name><name><surname>Sold&#x000e0;</surname><given-names>G.</given-names></name><etal/></person-group><article-title>SNCA and MAPT genes: independent and joint effects in Parkinson disease in the Italian population</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2012</year><volume>18</volume><issue>3</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2011.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-84857442897</pub-id><pub-id pub-id-type="pmid">22104010</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>C. C.</given-names></name><name><surname>Plagnol</surname><given-names>V.</given-names></name><name><surname>Strange</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Dissection of the genetics of Parkinson's disease identifies an additional association 5&#x02032; of SNCA and multiple associated haplotypes at 17q21</article-title><source><italic>Human Molecular Genetics</italic></source><year>2011</year><volume>20</volume><issue>2</issue><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq469</pub-id><pub-id pub-id-type="pmid">21044948</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic characteristics of Parkinson's disease (PD) cases and controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics </th><th colspan="2" align="center" rowspan="1">Cases = 583</th><th colspan="2" align="center" rowspan="1">Controls = 553</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Gender (<italic>n</italic>, %)<sup><italic>&#x02217;</italic></sup>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" rowspan="1" colspan="1">320</td><td align="center" rowspan="1" colspan="1">54.9 </td><td align="center" rowspan="1" colspan="1">286</td><td align="center" rowspan="1" colspan="1">51.7 </td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" rowspan="1" colspan="1">263</td><td align="center" rowspan="1" colspan="1">45.1 </td><td align="center" rowspan="1" colspan="1">267</td><td align="center" rowspan="1" colspan="1">48.3 </td></tr><tr><td align="left" rowspan="1" colspan="1">Age at collection (mean, SD)<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">65.10 </td><td align="center" rowspan="1" colspan="1">8.90 </td><td align="center" rowspan="1" colspan="1">65.37 </td><td align="center" rowspan="1" colspan="1">9.03 </td></tr><tr><td align="left" rowspan="1" colspan="1">Age at onset (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003c;50</td><td align="center" rowspan="1" colspan="1">131</td><td align="center" rowspan="1" colspan="1">22.5</td><td align="center" rowspan="1" colspan="1">n.a.</td><td align="center" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02267;50</td><td align="center" rowspan="1" colspan="1">452</td><td align="center" rowspan="1" colspan="1">77.5</td><td align="center" rowspan="1" colspan="1">n.a.</td><td align="center" rowspan="1" colspan="1">n.a.</td></tr></tbody></table><table-wrap-foot><fn><p>All the subjects were ethnic Hans; <sup><italic>&#x02217;</italic></sup>PD compared with controls by gender: <italic>P</italic> &#x0003e; 0.05; <sup>&#x02020;</sup>PD compared with controls by age: <italic>P</italic> &#x0003e; 0.05; n.a.: not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>PCR and Snapshot probe primer sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Polymorphisms</th><th align="center" rowspan="1" colspan="1">Primers</th><th align="left" rowspan="1" colspan="1">Sequence 5&#x02032; &#x02192; 3&#x02032;</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">LRRK2</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="3" align="left" colspan="1">&#x02003;rs1491942</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="left" rowspan="1" colspan="1">CAGGCTTGGGCAATTTCTAA</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="left" rowspan="1" colspan="1">GCCTATTGTGCTTCCTGCTC</td></tr><tr><td align="center" rowspan="1" colspan="1">Probe</td><td align="left" rowspan="1" colspan="1">40Ts+CAGGCTCCCCTGGGTT</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SNCA</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="3" align="left" colspan="1">&#x02003;rs2301134</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="left" rowspan="1" colspan="1">ATCACGCTGGATTTGTCTCC</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="left" rowspan="1" colspan="1">CACGGTCACAGGTTACAACG</td></tr><tr><td align="center" rowspan="1" colspan="1">Probe</td><td align="left" rowspan="1" colspan="1"> 41Ts+GACTCTTCCTTAGTAGTCTCCC</td></tr><tr><td rowspan="3" align="left" colspan="1">&#x02003;rs356221</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="left" rowspan="1" colspan="1">TGCCATAGAAACAACGAGGA</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="left" rowspan="1" colspan="1">TTGAAGAACCCAAAATGCAA</td></tr><tr><td align="center" rowspan="1" colspan="1">Probe</td><td align="left" rowspan="1" colspan="1">24Ts+AAGAGAAGCCATCCTAGT</td></tr><tr><td rowspan="3" align="left" colspan="1">&#x02003;rs2301135</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="left" rowspan="1" colspan="1">ACTTAACGTGAGGCGCAAAA</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="left" rowspan="1" colspan="1">CGTCCTCCTCCTCCTAGTCC</td></tr><tr><td align="center" rowspan="1" colspan="1">Probe</td><td align="left" rowspan="1" colspan="1">54Ts+CCGGGAGAGGGGCGGG</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IGTA8</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="3" align="left" colspan="1">&#x02003;rs7077361</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="left" rowspan="1" colspan="1">TGCGAAAACTATTTGGTGAAA</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="left" rowspan="1" colspan="1">CCCACCCACCAAATCTCTAA</td></tr><tr><td align="center" rowspan="1" colspan="1">Probe</td><td align="left" rowspan="1" colspan="1">31Ts+GAAATCATCTAGGGGATA</td></tr></tbody></table></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of the genotype frequencies and the allele frequencies of <italic>LRRK2</italic>, <italic>SNCA</italic>, and <italic>ITGA8</italic> polymorphisms.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Gene SNP</th><th rowspan="2" align="center" colspan="1">Group</th><th colspan="6" align="center" rowspan="1">Genotype <italic>n</italic>%</th><th rowspan="2" align="center" colspan="1">
<italic>P</italic>
<sub>HWE</sub>
</th><th align="center" rowspan="1" colspan="1">Allele Min/Maj</th><th rowspan="2" align="center" colspan="1">MAF<sup>a</sup>
</th><th rowspan="2" align="center" colspan="1">MAF<sup>b</sup>
</th><th rowspan="2" align="center" colspan="1">OR (95% CI)</th><th rowspan="2" align="center" colspan="1">
<italic>P</italic>
</th><th rowspan="2" align="center" colspan="1">Power<sup>c</sup>
</th></tr><tr><th colspan="2" align="center" rowspan="1">CC</th><th colspan="2" align="center" rowspan="1">GC</th><th colspan="2" align="center" rowspan="1">GG</th><th align="center" rowspan="1" colspan="1">G/C</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>LRRK2</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="6" align="left" colspan="1">rs1491942</td><td align="center" rowspan="1" colspan="1">Patients total</td><td align="center" rowspan="1" colspan="1">291</td><td align="center" rowspan="1" colspan="1">49.9 </td><td align="center" rowspan="1" colspan="1">240</td><td align="center" rowspan="1" colspan="1">41.2</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">8.9</td><td align="center" rowspan="1" colspan="1">0.84 </td><td align="center" rowspan="1" colspan="1">344/822</td><td align="center" rowspan="1" colspan="1">0.30 </td><td align="center" rowspan="1" colspan="1">0.36 </td><td rowspan="2" align="center" colspan="1">1.884 (1.546&#x02013;2.297)</td><td rowspan="2" align="center" colspan="1">2.60<italic>E</italic> &#x02212; 10<sup><italic>&#x02217;</italic></sup>
</td><td rowspan="2" align="center" colspan="1">1.00 </td></tr><tr><td align="center" rowspan="1" colspan="1">Controls total </td><td align="center" rowspan="1" colspan="1">372</td><td align="center" rowspan="1" colspan="1">67.3 </td><td align="center" rowspan="1" colspan="1">161</td><td align="center" rowspan="1" colspan="1">29.1</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">3.6</td><td align="center" rowspan="1" colspan="1">0.67 </td><td align="center" rowspan="1" colspan="1">201/905</td><td align="center" rowspan="1" colspan="1">0.18 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">EOPD</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">49.6 </td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">41.2</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">9.2</td><td align="center" rowspan="1" colspan="1">0.84 </td><td align="center" rowspan="1" colspan="1">78/184</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.924 (1.244&#x02013;2.976)</td><td rowspan="2" align="center" colspan="1">3.03<italic>E</italic> &#x02212; 03<sup><italic>&#x02217;</italic></sup>
</td><td rowspan="2" align="center" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x0003c; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">68.5 </td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">26.9</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4.6</td><td align="center" rowspan="1" colspan="1">0.33 </td><td align="center" rowspan="1" colspan="1">39/177</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">LOPD</td><td align="center" rowspan="1" colspan="1">226</td><td align="center" rowspan="1" colspan="1">50.0 </td><td align="center" rowspan="1" colspan="1">186</td><td align="center" rowspan="1" colspan="1">41.2</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">8.8</td><td align="center" rowspan="1" colspan="1">0.82 </td><td align="center" rowspan="1" colspan="1">266/638</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.874 (1.500&#x02013;2.340)</td><td rowspan="2" align="center" colspan="1">2.46<italic>E</italic> &#x02212; 08<sup><italic>&#x02217;</italic></sup>
</td><td rowspan="2" align="center" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x02267; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">298</td><td align="center" rowspan="1" colspan="1">67.0 </td><td align="center" rowspan="1" colspan="1">132</td><td align="center" rowspan="1" colspan="1">29.7</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">3.4</td><td align="center" rowspan="1" colspan="1">0.87 </td><td align="center" rowspan="1" colspan="1">162/728</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td colspan="2" align="center" rowspan="1">GG</td><td colspan="2" align="center" rowspan="1">AG</td><td colspan="2" align="center" rowspan="1">AA</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>SNCA</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="6" align="left" colspan="1">rs2301134</td><td align="center" rowspan="1" colspan="1">Patients total</td><td align="center" rowspan="1" colspan="1">437</td><td align="center" rowspan="1" colspan="1">75.0 </td><td align="center" rowspan="1" colspan="1">132 </td><td align="center" rowspan="1" colspan="1">22.6</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">2.4 </td><td align="center" rowspan="1" colspan="1">0.29 </td><td align="center" rowspan="1" colspan="1">160/1006</td><td align="center" rowspan="1" colspan="1">0.14 </td><td align="center" rowspan="1" colspan="1">0.20 </td><td rowspan="2" align="center" colspan="1">1.237 (0.964&#x02013;1.588)</td><td rowspan="2" align="center" colspan="1">9.43<italic>E</italic> &#x02013; 02</td><td rowspan="2" align="center" colspan="1">0.42 </td></tr><tr><td align="center" rowspan="1" colspan="1">Controls total</td><td align="center" rowspan="1" colspan="1">436</td><td align="center" rowspan="1" colspan="1">78.8 </td><td align="center" rowspan="1" colspan="1">108 </td><td align="center" rowspan="1" colspan="1">19.5</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">1.6 </td><td align="center" rowspan="1" colspan="1">0.40 </td><td align="center" rowspan="1" colspan="1">126/980</td><td align="center" rowspan="1" colspan="1">0.11 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">EOPD</td><td align="center" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">74.0 </td><td align="center" rowspan="1" colspan="1">32 </td><td align="center" rowspan="1" colspan="1">24.4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1.5 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">36/226</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.561 (0.875&#x02013;2.786)</td><td rowspan="2" align="center" colspan="1">1.29<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x0003c; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">81.5 </td><td align="center" rowspan="1" colspan="1">20 </td><td align="center" rowspan="1" colspan="1">18.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0 </td><td align="center" rowspan="1" colspan="1">0.59 </td><td align="center" rowspan="1" colspan="1">20/196</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">LOPD</td><td align="center" rowspan="1" colspan="1">340</td><td align="center" rowspan="1" colspan="1">75.2 </td><td align="center" rowspan="1" colspan="1">100 </td><td align="center" rowspan="1" colspan="1">22.1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2.7 </td><td align="center" rowspan="1" colspan="1">0.16 </td><td align="center" rowspan="1" colspan="1">124/780</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.176 (0.891&#x02013;1.552)</td><td rowspan="2" align="center" colspan="1">2.52<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x02267; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">348</td><td align="center" rowspan="1" colspan="1">78.2 </td><td align="center" rowspan="1" colspan="1">88 </td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">2.0 </td><td align="center" rowspan="1" colspan="1">0.25 </td><td align="center" rowspan="1" colspan="1">106/784</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td colspan="2" align="center" rowspan="1">AA</td><td colspan="2" align="center" rowspan="1">TA</td><td colspan="2" align="center" rowspan="1">TT</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">T/A</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="6" align="left" colspan="1">rs356221</td><td align="center" rowspan="1" colspan="1">Patients total</td><td align="center" rowspan="1" colspan="1">210</td><td align="center" rowspan="1" colspan="1">36.0 </td><td align="center" rowspan="1" colspan="1">282</td><td align="center" rowspan="1" colspan="1">48.4</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">15.6 </td><td align="center" rowspan="1" colspan="1">0.86 </td><td align="center" rowspan="1" colspan="1">464/702</td><td align="center" rowspan="1" colspan="1">0.40 </td><td align="center" rowspan="1" colspan="1">0.40 </td><td rowspan="2" align="center" colspan="1">1.167 (1.985&#x02013;1.382)</td><td rowspan="2" align="center" colspan="1">7.50<italic>E</italic> &#x02212; 02</td><td rowspan="2" align="center" colspan="1">0.45 </td></tr><tr><td align="center" rowspan="1" colspan="1">Controls total</td><td align="center" rowspan="1" colspan="1">231</td><td align="center" rowspan="1" colspan="1">41.8 </td><td align="center" rowspan="1" colspan="1">244</td><td align="center" rowspan="1" colspan="1">44.1</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">14.1 </td><td align="center" rowspan="1" colspan="1">0.31 </td><td align="center" rowspan="1" colspan="1">400/706</td><td align="center" rowspan="1" colspan="1">0.36 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">EOPD</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">32.8 </td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">51.1</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">16.0 </td><td align="center" rowspan="1" colspan="1">0.59 </td><td align="center" rowspan="1" colspan="1">109/153</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.286 (0.887&#x02013;1.864)</td><td rowspan="2" align="center" colspan="1">1.84<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x0003c; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">42.6 </td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">43.5</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">13.9 </td><td align="center" rowspan="1" colspan="1">0.67 </td><td align="center" rowspan="1" colspan="1">77/139</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">LOPD</td><td align="center" rowspan="1" colspan="1">167</td><td align="center" rowspan="1" colspan="1">36.9 </td><td align="center" rowspan="1" colspan="1">215</td><td align="center" rowspan="1" colspan="1">47.6</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">15.5 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">355/549</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.135 (0.938&#x02013;1.374)</td><td rowspan="2" align="center" colspan="1">1.93<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x02267; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">185</td><td align="center" rowspan="1" colspan="1">41.6 </td><td align="center" rowspan="1" colspan="1">197</td><td align="center" rowspan="1" colspan="1">44.3</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">14.2 </td><td align="center" rowspan="1" colspan="1">0.36 </td><td align="center" rowspan="1" colspan="1">323/567</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td colspan="3" align="center" rowspan="1">CC</td><td colspan="3" align="center" rowspan="1">GG</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">G/C</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="6" align="left" colspan="1">rs2301135</td><td align="center" rowspan="1" colspan="1">Patients total</td><td align="center" rowspan="1" colspan="1">544</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">93.3 </td><td align="center" rowspan="1" colspan="1">39 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">6.7 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">78/1088</td><td align="center" rowspan="1" colspan="1">0.07 </td><td align="center" rowspan="1" colspan="1">0.19 </td><td rowspan="2" align="center" colspan="1">7.857 (4.046&#x02013;15.258)</td><td rowspan="2" align="center" colspan="1">9.12<italic>E</italic> &#x02212; 13<sup><italic>&#x02217;</italic></sup>
</td><td rowspan="2" align="center" colspan="1">1.00 </td></tr><tr><td align="center" rowspan="1" colspan="1">Controls total</td><td align="center" rowspan="1" colspan="1">548</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">99.1 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.9 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">10/1096</td><td align="center" rowspan="1" colspan="1">0.01 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">EOPD</td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">98.5 </td><td align="center" rowspan="1" colspan="1">2 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">1.5 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">4/258</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.016 (1.000&#x02013;1.031)</td><td rowspan="2" align="center" colspan="1">1.30<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x0003c; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">108</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">0 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.0 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">0/216</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">LOPD</td><td align="center" rowspan="1" colspan="1">415</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">91.8 </td><td align="center" rowspan="1" colspan="1">37 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">8.2 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">74/830</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">7.846 (4.026&#x02013;15.288)</td><td rowspan="2" align="center" colspan="1">1.45<italic>E</italic> &#x02212; 12<sup><italic>&#x02217;</italic></sup>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x02267; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">440</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">98.9 </td><td align="center" rowspan="1" colspan="1">5 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">1.1 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">10/880</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td colspan="3" align="center" rowspan="1">TT</td><td colspan="3" align="center" rowspan="1">CT</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ITGA8</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td rowspan="6" align="left" colspan="1">rs7077361</td><td align="center" rowspan="1" colspan="1">Patients total</td><td align="center" rowspan="1" colspan="1">580</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">99.5 </td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.5 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">3/1163</td><td align="center" rowspan="1" colspan="1">0.00 </td><td align="center" rowspan="1" colspan="1">0.00 </td><td rowspan="2" align="center" colspan="1">2.85 (0.296&#x02013;27.443)</td><td rowspan="2" align="center" colspan="1">6.25<italic>E</italic> &#x02212; 01</td><td rowspan="2" align="center" colspan="1">0.34 </td></tr><tr><td align="center" rowspan="1" colspan="1">Controls total</td><td align="center" rowspan="1" colspan="1">552</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">99.8 </td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.2 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">1/1105</td><td align="center" rowspan="1" colspan="1">0.00 </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">EOPD</td><td align="center" rowspan="1" colspan="1">131</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.0 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">0/262</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">0.995 (0.986&#x02013;1.004)</td><td rowspan="2" align="center" colspan="1">4.52<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x0003c; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">107</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">99.1 </td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.9 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">0/0</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">LOPD</td><td align="center" rowspan="1" colspan="1">449</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">99.3 </td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.7 </td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">3/449</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td rowspan="2" align="center" colspan="1">1.003 (1.000&#x02013;1.007)</td><td rowspan="2" align="center" colspan="1">2.50<italic>E</italic> &#x02212; 01</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">Controls &#x02267; 50&#x02009;y</td><td align="center" rowspan="1" colspan="1">445</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.0 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">0/445</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr></tbody></table><table-wrap-foot><fn><p>EOPD: early onset Parkinson's disease; LOPD: late-onset Parkinson's disease; <italic>P</italic>
<sub>HWE</sub>: <italic>P</italic> value obtained in the Hardy-Weinberg equilibrium (HWE) test; <italic>&#x02217;</italic>: significant <italic>P</italic> value obtained in the case-control analysis; Min: minor; Maj: major; MAF: minor allele frequency; a: this study; b: 1000 genomes (Southern Han Chinese); c: power was calculated by Power and Sample Size Calculations version 3.1.2.</p></fn></table-wrap-foot></table-wrap></floats-group></article>